N-Acetylcysteine to Combat COVID-19: An Evidence Review
Zhongcheng Shi,1,2 Carlos A Puyo3 1Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; 2Department of Pathology, Texas Children’s Hospital, Houston, TX, USA; 3Department of Anesthesia and Critical Care, Holy Family Hospital, Steward Health Care, Methuen, M...
Guardado en:
Autores principales: | Shi Z, Puyo CA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7462d7358ee64346ab9b8d5838d7d199 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nephroprotective Effect of Coenzyme Q10 alone and in Combination with N-acetylcysteine in Diabetic Nephropathy
por: Mahajan Manojkumar S., et al.
Publicado: (2021) -
N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
por: Wong KK, et al.
Publicado: (2021) -
An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
por: Mulaw Belete T
Publicado: (2020) -
Cardiovascular Considerations in COVID19: A Comprehensive Review
por: Keihanian F, et al.
Publicado: (2020) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi A
Publicado: (2020)